Company overview
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing PBH with another company.
| Daily close (USD) | $47.87 |
| Market capitalization (USD) | $2,267,818,368.14 |
| Price / earnings (TTM) | 13.18 |
| Price / book | 1.18 |
No matching rows. Clear the filter to see all records.
Read PBH's valuation metrics
Company size
Prestige Consumer Healthcare Inc.'s recorded market capitalization is $2,267,818,368.14. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
PBH's recorded P/E is 13.18: about $13.18 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
PBH's recorded price-to-book ratio is 1.18. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Prestige Consumer Healthcare Inc. with Aurora
Use the snapshot above to ask a specific question about PBH. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow PBH's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.